| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.42B | +20.4% |
| Cost of Revenue | $286.5M | +73.7% |
| R&D Expense | $1.64B | +12.4% |
| SG&A Expense | $1.28B | +29.1% |
| Operating Income | -$1.79B | -24.4% |
| Interest Expense | $21.7M | -25.8% |
| Pre-tax Income | -$1.96B | -36.3% |
| Income Tax | $42.8M | +269.5% |
| Net Income | -$2.00B |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.87B | -11.6% |
| Short-term Investments | $665.3M | -70.3% |
| Accounts Receivable | $173.2M | -64.2% |
| Inventory | $282.3M | +16.4% |
| Current Assets | $5.21B | -31.6% |
| Total Assets | $6.38B | -26.2% |
| Current Liabilities | $1.47B | -8.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.50B | -15.2% |
| Capital Expenditures | $325.4M | +23.8% |
| Investing Cash Flow | $1.08B | +68.1% |
| Financing Cash Flow | -$19.0M | -100.5% |
| Free Cash Flow | -$1.82B | -16.7% |
| -41.8% |
| EPS (Basic) | -$1.49 | -27.4% |
| EPS (Diluted) | -$1.49 | -27.4% |
| Long-term Debt |
| $209.1M |
| +3.5% |
| Total Liabilities | $2.00B | -16.9% |
| Stockholders' Equity | $4.38B | -29.8% |